Dr Reddy S Laboratories Limited Revenue Growth Rates (RDY), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Dr Reddy s Laboratories Limited  (NYSE: RDY)
 

RDY's Revenue Growth by Quarter and Year

Dr Reddy S Laboratories Limited's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RDY Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December 3,580.00
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 3,580.00

RDYs Annual Revenue
Dr Reddy S Laboratories Limited's Revenue in the fiscal year 2026 $ 3,580.00 millions
Dr Reddy S Laboratories Limited's Revenue in the fiscal year 2025 $ 3,811.00 millions
Dr Reddy S Laboratories Limited's Revenue in the fiscal year 2024 $ 3,350.00 millions
Dr Reddy S Laboratories Limited's Revenue in the fiscal year 2023 $ 2,992.00 millions
Dr Reddy S Laboratories Limited's Revenue in the fiscal year 2022 $ 2,826.00 millions




RDY Revenue fourth quarter 2026 Y/Y Growth Comment
Dr Reddy S Laboratories Limited reported decrease in Revenue in the fourth quarter 2026 by -6.06% to $ 3,580.00 millions, from the same quarter in 2025.
The decrease in the fourth quarter 2026 Dr Reddy S Laboratories Limited's Revenue compares unfavorably to the Company's average Revenue growth of 2.1%.

Looking into fourth quarter 2026 results within Major Pharmaceutical Preparations industry 77 other companies have achieved higher Revenue growth. While Dr Reddy S Laboratories Limited' s Revenue decline of -6.06% ranks overall at the positon no. 1359 in the fourth quarter 2026.


RDY Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December -6.06 % 13.76 % 11.97 % 5.87 %
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   -6.06 % 13.76 % 11.97 % -

Financial Statements
Dr Reddy S Laboratories Limited's fourth quarter 2026 Revenue $ 3,580.00 millions RDY's Income Statement
Dr Reddy S Laboratories Limited's fourth quarter 2025 Revenue $ 3,811.00 millions Quarterly RDY's Income Statement


RDY Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   -6.06 % 13.76 % 11.97 % -


Back to RDY Growth rate Comparisons >> Back to RDY Growth rate Comparisons >>


Revenue fourth quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #78
Healthcare Sector #228
Overall #1359

Revenue Y/Y Growth Statistics
High Average Low
12 % 2.1 % -30.25 %
(Mar 31 2021)   (Mar 31 2019)
Revenue fourth quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #78
Healthcare Sector #228
Overall #1359
Revenue Y/Y Growth Statistics
High Average Low
12 % 2.1 % -30.25 %
(Mar 31 2021)   (Mar 31 2019)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Dr Reddy S Laboratories Limited's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RDY's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RDY's IV. Quarter Q/Q Revenue Comment


Dr Reddy S Laboratories Limited's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Mar 31 2022)
Cumulative Revenue 12 Months Ending $ 3,580.00 $ 3,811.00 $ 3,350.00 $ 2,992.00 $ 2,826.00
Y / Y Revenue Growth (TTM) -6.06 % 13.76 % 11.97 % 5.87 % 8.94 %
Year on Year Revenue Growth Overall Ranking # 1359 # 1227 # 1214 # 0 # 0
Seqeuential Revenue Change (TTM) -6.06 % 13.76 % 11.97 % 5.87 % 8.94 %
Seq. Revenue Growth (TTM) Overall Ranking # 1359 # 1227 # 1214 # 0 # 0


Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2026 Dr Reddy S Laboratories Limited reported a decrease in Revenue by -6.06% year on year, to $3,580 millions, compare to the 13.76% growth at Mar 31 2025.

In the Healthcare sector 227 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1227 to 1359.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 78
Healthcare Sector # 228
Overall # 1359

Revenue TTM Y/Y Growth Statistics
High Average Low
12 %
 2.1 %
-30.25 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 78
Sector # 228
S&P 500 # 1359
Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2026 Dr Reddy S Laboratories Limited reported a decrease in Revenue by -6.06% year on year, to $3,580 millions, compare to the 13.76% growth at Mar 31 2025.

In the Healthcare sector 227 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1227 to 1359.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 78
Healthcare Sector # 228
Overall # 1359

Revenue TTM Y/Y Growth Statistics
High Average Low
12 %
2.1 %
-30.25 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 78
Sector # 228
S&P 500 # 1359




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RDY's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Dr Reddy s Laboratories Limited-6.06%$ -6.061 millions


About Dr Reddy S Laboratories Limited Revenue Growth Rates (RDY), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Dr Reddys Laboratories Ltd (CIK 1135951).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001575872-26-000381
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Dr Reddys Laboratories Ltd’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.